Rheumatoid arthritis patients who failed to respond to initial treatment with rituximab (a chimeric monoclonal antibody against the protein CD20) can still be successfully re-treated with a second ...
A recent study by Swedish researchers found that rheumatoid arthritis patients did not experience an elevated cancer risk in the first six years after starting anti-tumor necrosis factor therapy.
... have brought dramatic gains in treatment for rheumatoid arthritis patients. Etanercept, the only FDA-approved biologic for ... rate of 0.03 MIIs per patient year. This rate did not increase with long- ...
... chronic, inflammatory disease of unknown origin, rheumatoid arthritis (RA) affects about 1 percent ... adults, studied the cancer incidence in RA patients treated with MTX by local doctors. Their findings ...
... critical that dental professionals and medical professionals work together when treating a patient living with rheumatoid arthritis. This partnership will assure that both the oral and overall health ...
... modest beneficial effect of anakinra for rheumatoid arthritis patients, but warns against potential risks ... anakinra trials involving 2,876 patients, researchers found anakinra reduced pain and stiffness ...
... that gum disease tends to be prevalent in rheumatoid arthritis patients.
Both inflammatory diseases share ... divided into four groups. Two groups of patients were receiving a new group of anti-TNF-α ...
Over half (63 percent) of patients with rheumatoid arthritis (RA) also suffer from psychiatric disorders, with the majority of these (87 percent) occurring in the depressive spectrum, according to a ...
... ., Ph.D., evaluated 218 RA patients who completed self-administered questionnaires that surveyed ... 133 married RA patients completed questionnaires, including the Rheumatoid Arthritis Disease Activity ...
Despite recent advances in anti-inflammatory therapy, many rheumatoid arthritis patients continue to suffer from pain. Researchers have found that inflammation is associated with heightened pain ...
... Paris, France, show that over half of rheumatoid arthritis patients resistant to methotrexate monotherapy improved ... shown that 24 ABA and 23 IFX patients achieved LDAS (but not remission) at six months ...
... – infliximab, etanercept and adalimumab – which have had a dramatic effect on the symptoms of rheumatoid arthritis patients, protecting the joints from further deterioration in the vast majority of ...
... drugs influence HBV infection in IBD patients. A research article to be published on 28 May 2008, ... 1 case of fulminant hepatitis in rheumatoid arthritis patient both with positive HBsAg and treated ...
... was rated more severe at six months, compared to patients whose RA first became symptomatic in summer. Patients with first symptoms in spring showed poorer radiographic outcome compared to summer- ...
... Dr. Reed. "We can apply these same procedures to determine the most effective treatments for rheumatoid arthritis patients."
Insulin-Like Proteins Linked to Age-Related Bone Loss in Men and ...
